{"title_page": "JWH-120", "text_new": "{{Drugbox\n| IUPAC_name = (4-Methyl-1-naphthalenyl)(1-propyl-1''H''-indol-3-yl)methanone\n| image = JWH-120.png\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| legal_US = Schedule I\n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| metabolism =  \n| elimination_half-life =  \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 824955-98-8\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = J6M7L6J6PN\n| PubChem = 11461586\n| ChemSpiderID      = 9636426\n| ChEMBL = 497811\n\n<!--Chemical data-->\n| C=23 | H=21 | N=1 | O=1\n| smiles = CCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)C\n| StdInChI          = 1S/C23H21NO/c1-3-14-24-15-21(19-10-6-7-11-22(19)24)23(25)20-13-12-16(2)17-8-4-5-9-18(17)20/h4-13,15H,3,14H2,1-2H3\n| StdInChIKey       = DUBUGSKBMMXSOU-UHFFFAOYSA-N\n}}\n\n'''JWH-120''' is a synthetic cannabimimetic that was discovered by [[John W. Huffman]]. It is the ''N''-propyl analog of [[JWH-122]]. It is a potent and selective ligand for the [[Cannabinoid receptor 2|CB<sub>2</sub> receptor]], but a weaker ligand for the [[Cannabinoid receptor 1|CB<sub>1</sub> receptor]].  It has a binding affinity of ''K''<sub>i</sub> = 6.1 \u00b1 0.7 nM at the CB<sub>2</sub> subtype and 173 times selectivity over the CB<sub>1</sub> subtype.<ref>{{cite journal | vauthors = Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR | display-authors = 6 | title = Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists | journal = Bioorganic & Medicinal Chemistry | volume = 13 | issue = 1 | pages = 89\u2013112 | date = January 2005 | pmid = 15582455 | doi = 10.1016/j.bmc.2004.09.050 }}</ref>\n\nIn the United States, all CB<sub>1</sub> receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-120 are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref>\n\n== See also ==\n\n* [[JWH-122]]\n* [[JWH-193]]\n* [[JWH-210]]\n* [[JWH-398]]\n\n== References ==\n{{reflist}}\n\n{{Cannabinoids}}\n{{cannabinoid-stub}}\n\n[[Category:JWH cannabinoids]]\n[[Category:Naphthoylindoles]]\n[[Category:CB1 receptor agonists]]\n[[Category:CB2 receptor agonists]]\n", "text_old": "{{Drugbox\n| IUPAC_name = (4-Methyl-1-naphthalenyl)(1-propyl-1''H''-indol-3-yl)methanone\n| image = JWH-120.png\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| legal_US = Schedule I\n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| metabolism =  \n| elimination_half-life =  \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 824955-98-8\n| PubChem = 11461586\n| ChemSpiderID      = 9636426\n| ChEMBL = 497811\n\n<!--Chemical data-->\n| C=23 | H=21 | N=1 | O=1\n| smiles = CCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)C\n| StdInChI          = 1S/C23H21NO/c1-3-14-24-15-21(19-10-6-7-11-22(19)24)23(25)20-13-12-16(2)17-8-4-5-9-18(17)20/h4-13,15H,3,14H2,1-2H3\n| StdInChIKey       = DUBUGSKBMMXSOU-UHFFFAOYSA-N\n}}\n\n'''JWH-120''' is a synthetic cannabimimetic that was discovered by [[John W. Huffman]]. It is the ''N''-propyl analog of [[JWH-122]]. It is a potent and selective ligand for the [[Cannabinoid receptor 2|CB<sub>2</sub> receptor]], but a weaker ligand for the [[Cannabinoid receptor 1|CB<sub>1</sub> receptor]].  It has a binding affinity of ''K''<sub>i</sub> = 6.1 \u00b1 0.7 nM at the CB<sub>2</sub> subtype and 173 times selectivity over the CB<sub>1</sub> subtype.<ref>{{cite journal | vauthors = Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR | display-authors = 6 | title = Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists | journal = Bioorganic & Medicinal Chemistry | volume = 13 | issue = 1 | pages = 89\u2013112 | date = January 2005 | pmid = 15582455 | doi = 10.1016/j.bmc.2004.09.050 }}</ref>\n\nIn the United States, all CB<sub>1</sub> receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-120 are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref>\n\n== See also ==\n\n* [[JWH-122]]\n* [[JWH-193]]\n* [[JWH-210]]\n* [[JWH-398]]\n\n== References ==\n{{reflist}}\n\n{{Cannabinoids}}\n{{cannabinoid-stub}}\n\n[[Category:JWH cannabinoids]]\n[[Category:Naphthoylindoles]]\n[[Category:CB1 receptor agonists]]\n[[Category:CB2 receptor agonists]]\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/JWH-120"}
